Search Results - "Ezponda, Teresa"
-
1
Molecular pathways: deregulation of histone h3 lysine 27 methylation in cancer-different paths, same destination
Published in Clinical cancer research (01-10-2014)“…Methylation of lysine 27 on histone H3 (H3K27me), a modification associated with gene repression, plays a critical role in regulating the expression of genes…”
Get full text
Journal Article -
2
EZH2 Is Required for Germinal Center Formation and Somatic EZH2 Mutations Promote Lymphoid Transformation
Published in Cancer cell (13-05-2013)“…The EZH2 histone methyltransferase is highly expressed in germinal center (GC) B cells and targeted by somatic mutations in B cell lymphomas. Here, we find…”
Get full text
Journal Article -
3
Uncovering perturbations in human hematopoiesis associated with healthy aging and myeloid malignancies at single-cell resolution
Published in eLife (11-01-2023)“…Early hematopoiesis is a continuous process in which hematopoietic stem and progenitor cells (HSPCs) gradually differentiate toward specific lineages. Aging…”
Get full text
Journal Article -
4
Histone methyltransferase MMSET/NSD2 alters EZH2 binding and reprograms the myeloma epigenome through global and focal changes in H3K36 and H3K27 methylation
Published in PLoS genetics (01-09-2014)“…Overexpression of the histone methyltransferase MMSET in t(4;14)+ multiple myeloma patients is believed to be the driving factor in the pathogenesis of this…”
Get full text
Journal Article -
5
UTX/KDM6A Loss Enhances the Malignant Phenotype of Multiple Myeloma and Sensitizes Cells to EZH2 inhibition
Published in Cell reports (Cambridge) (17-10-2017)“…Loss or inactivation of the histone H3K27 demethylase UTX occurs in several malignancies, including multiple myeloma (MM). Using an isogenic cell system, we…”
Get full text
Journal Article -
6
Characterization of complete lncRNAs transcriptome reveals the functional and clinical impact of lncRNAs in multiple myeloma
Published in Leukemia (01-05-2021)“…Multiple myeloma (MM) is an incurable disease, whose clinical heterogeneity makes its management challenging, highlighting the need for biological features to…”
Get full text
Journal Article -
7
Deregulation of linc-PINT in acute lymphoblastic leukemia is implicated in abnormal proliferation of leukemic cells
Published in Oncotarget (27-02-2018)“…Long Non-Coding RNAs (lncRNAs) are functional RNAs longer than 200 nucleotides in length. Several lncRNAs are involved in cell proliferation and are…”
Get full text
Journal Article -
8
Single-cell transcriptional profile of CD34+ hematopoietic progenitor cells from del(5q) myelodysplastic syndromes and impact of lenalidomide
Published in Nature communications (20-06-2024)“…While myelodysplastic syndromes with del(5q) (del(5q) MDS) comprises a well-defined hematological subgroup, the molecular basis underlying its origin remains…”
Get full text
Journal Article -
9
Alternative splicing: an emerging topic in molecular and clinical oncology
Published in The lancet oncology (01-04-2007)“…Summary Alternative pre-mRNA splicing is a key molecular event that allows for protein diversity. Through this process, a single gene increases its coding…”
Get full text
Journal Article -
10
SimiC enables the inference of complex gene regulatory dynamics across cell phenotypes
Published in Communications biology (12-04-2022)“…Single-cell RNA-Sequencing has the potential to provide deep biological insights by revealing complex regulatory interactions across diverse cell phenotypes at…”
Get full text
Journal Article -
11
Expression of Tumor-Derived Vascular Endothelial Growth Factor and Its Receptors Is Associated With Outcome in Early Squamous Cell Carcinoma of the Lung
Published in Journal of clinical oncology (01-04-2012)“…Antiangiogenic therapies targeting the vascular endothelial growth factor (VEGF) pathway have yielded more modest clinical benefit to patients with…”
Get full text
Journal Article -
12
Deregulation of the Ras-Erk Signaling Axis Modulates the Enhancer Landscape
Published in Cell reports (Cambridge) (25-08-2015)“…Unrestrained receptor tyrosine kinase (RTK) signaling and epigenetic deregulation are root causes of tumorigenesis. We establish linkage between these…”
Get full text
Journal Article -
13
The Oncoprotein SF2/ASF Promotes Non-Small Cell Lung Cancer Survival by Enhancing Survivin Expression
Published in Clinical cancer research (15-08-2010)“…SF2/ASF is a splicing factor recently described as an oncoprotein. In the present work, we examined the role of SF2/ASF in human non-small cell lung cancer…”
Get full text
Journal Article -
14
Development of a novel splice array platform and its application in the identification of alternative splice variants in lung cancer
Published in BMC genomics (03-06-2010)“…Microarrays strategies, which allow for the characterization of thousands of alternative splice forms in a single test, can be applied to identify differential…”
Get full text
Journal Article -
15
Mitochondria Are Required for Antigen-Specific T Cell Activation through Reactive Oxygen Species Signaling
Published in Immunity (Cambridge, Mass.) (21-02-2013)“…It is widely appreciated that T cells increase glycolytic flux during activation, but the role of mitochondrial flux is unclear. Here, we have shown that…”
Get full text
Journal Article -
16
Molecular Pathways: Deregulation of Histone 3 Lysine 27 Methylation in Cancer—Different Paths, Same Destination
Published in Clinical cancer research (01-07-2014)“…Methylation of lysine 27 on histone 3 (H3K27me), a modification associated with gene repression, plays a critical role in regulating the expression of genes…”
Get full text
Journal Article -
17
KDM6A regulates immune response genes in multiple myeloma
Published in Blood (03-10-2024)“…•KDM6A binds NLRC5 and CIITA loci and regulates their transcription in myeloma cells.•Decreased expression of NLRC5 and CIITA in KDM6A-deficient cell lines can…”
Get full text
Journal Article -
18
Bone Marrow Cytokines Concentrations in Myelodysplastic Neoplasms: Its Correlation with the Immune Populations and Clonal Hematopoiesis
Published in Blood (02-11-2023)“…Background: Myelodysplastic neoplasms (MDS) are a clonal, heterogenic disease of the hematopoietic stem cell. Pathophysiology is mainly related to intrinsic…”
Get full text
Journal Article -
19
The Transcriptional Impact of 5q Deletion in MDS at Single Cell Resolution
Published in Blood (02-11-2023)“…Introduction: Myelodysplastic syndromes with 5q deletion (del(5q) MDS) are characterized by two commonly deleted regions (CDRs): 5q31 and 5q32-33. Although…”
Get full text
Journal Article -
20
MMSET/WHSC1 enhances DNA damage repair leading to an increase in resistance to chemotherapeutic agents
Published in Oncogene (10-11-2016)“…MMSET/WHSC1 is a histone methyltransferase (HMT) overexpressed in t(4;14)+ multiple myeloma (MM) patients, believed to be the driving factor in the…”
Get full text
Journal Article